Literature DB >> 12825539

Degenerative sternoclavicular arthritis and hyperostosis.

Jeffrey S Noble1.   

Abstract

Symptomatic arthritic involvement of the sternoclavicular joint is relatively uncommon and can be a result of distant trauma, infection, and sternocostoclavicular hyperostosis, post-menopausal arthritis, condensing osteitis of the proximal clavicle, or secondary to an underlying arthropathy. Patients with degenerative osteoarthritis due to trauma most commonly have had either an anterior or posterior dislocation, subluxation, or periarticular fracture. Medical claviculectomy with or without ligamentous stabilization is indicated only in situations of painful primary and secondary rheumatoid arthritis, or in patients with neoplastic lesions. Numerous authors have recommended surgical reconstruction but few have reported series larger than two or three cases. This article reviews a few specific arthropathy conditions about the sternoclavicular joint and discusses their nonoperative and operative management.

Entities:  

Mesh:

Year:  2003        PMID: 12825539     DOI: 10.1016/s0278-5919(02)00097-2

Source DB:  PubMed          Journal:  Clin Sports Med        ISSN: 0278-5919            Impact factor:   2.182


  4 in total

Review 1.  Sternoclavicular joint.

Authors:  Rohit Dhawan; Rohit Amol Singh; Bernhard Tins; Stuart M Hay
Journal:  Shoulder Elbow       Date:  2018-04-02

2.  Sternocostoclavicular hyperostosis: a review.

Authors:  Matthew B Carroll
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-04       Impact factor: 5.346

3.  Sclerosis of the clavicle--A challenging diagnosis.

Authors:  Ty A Davis; Jacklyn Garcia; Thelma Rocio Jimenez Mosquea; Stephanie D Zarate; Andrew A Renshaw; Ana C Belzarena
Journal:  Radiol Case Rep       Date:  2022-05-06

4.  Diagnostic yield of CT-guided sampling in suspected sternoclavicular joint infection.

Authors:  Atul K Taneja; Guillaume Bierry; F Joseph Simeone; Connie Y Chang; Miriam A Bredella; Martin Torriani
Journal:  Skeletal Radiol       Date:  2012-11-20       Impact factor: 2.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.